Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9227
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 36 $154,913 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $154,913 Current and potential, with all options
- Last date to order 10% complete
- IDV ceiling 3% used
- $4,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,999,999, is an Indefinite Delivery Contract (IDC) valid through December 2036 that allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide.
The contract covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This single-award IDC positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) healthcare sites. The original solicitation, expected to be issued in March 2024, will establish Pharmaceutical Prime Vendor Global Program Generation V contracts with an estimated total value of $30.3 billion to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet.
Task orders
Show all 36
Quick answers
Who was awarded contract SPE2DR25D9227?
SPE2DR25D9227 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 1, 2025.
How much is contract SPE2DR25D9227 worth?
Orders under SPE2DR25D9227 have obligated $154,913. SPE2DR25D9227's own ceiling is $4,999,999.
How many orders have been placed under contract SPE2DR25D9227?
36 orders have been placed under SPE2DR25D9227, the latest on July 21, 2026.
Who can order from contract SPE2DR25D9227?
SPE2DR25D9227 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9227 competed?
The extent of competition for SPE2DR25D9227 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV